Home
About Us
Vision
People
Team
Senior Advisory
Medical Advisory
Consultants
Board
Funding
Technology
Platforms
Case Studies
Collaborations
Publications
White Paper
Pipeline
Media
Awards & Recognition
Newsroom
Blog
YouTube
Research Oncology Solutions (ROS)
Drug Discovery
Drug Repurposing
Clinical Translations
Gallery
Contact Us
Careers
X
Home
About Us
Vision
People
Team
Senior Advisory
Medical Advisory
Consultants
Board
Funding
Investors
Grants
Technology
Platforms
Case Studies
Collaborations
Publications
Research Oncology Solutions
Drug Discovery/ Drug Repurposing/Clinical Translations
Media
Awards & Recognitions
Newsroom
Blog
Youtube
Gallery
People
Labs
Main Lab
Tissue Culture
Animal House
Incubator
Instrumentation
Contact Us
Careers
Home
About Us
Vision
People
Team
Senior Advisory
Medical Advisory
Consultants
Board
Funding
Technology
Platforms
Case Studies
Collaborations
Publications
White Paper
Pipeline
Media
Awards & Recognition
Newsroom
Blog
YouTube
Research Oncology Solutions (ROS)
Drug Discovery
Drug Repurposing
Clinical Translations
Gallery
Contact Us
Careers
X
Publications
EACR Annual Conference, 2025, Lisbon, Portugal
EACR25-1305: Positioning of MS-AP-030 as a clinical candidate in an adjuvant setting to delay metastasis in colorectal cancer
Molecular Oncology 19 (Suppl. 1) (2025) 1–895, p 664.
EACR 2024 Annual Conference, Rotterdam, Netherlands
EACR2024-0521: Identification and positioning of an approved drug, MS-AP-031, to delay metastasis of primary colorectal cancer patients in an adjuvant setting
Molecular Oncology, 18 (Suppl. 1), 2024, 1-495, p 368
Swiss Biotech Day, Basel, April 22-23, 2024
A translationally relevant, 3D spheroid-based medium throughput screening system that differentiates between cells with variable plasticity.
CNIO-Caixa research Frontiers Meetings, Spain, Nov 6-8, 2023
A Systems Biology Approach in Unveiling Cancer Metastasis Drug Discovery & Retrospective Clinical Trial Validation.
EACR 2023 Annual Conference, Torino, Italy
EACR23-0346: Effect of Approved Non-Oncology Drugs on the Metastatic Process: Risks & Benefits
Molecular Oncology 17 (Suppl. 1) (2023) 1–597, page 455
Official Abstract Book, Page 33
AACR 2023 Annual Conference, Orlando, USA
Abstract 3940: Validation of TFX1, a first-in-class target for cancer metastasis Arnab Roy Chowdhury; Manoj Pandre; Chinmaya Amarkanth; Debabani Roy Chowdhury; John Ellingboe
Cancer Research, Volume 83, Issue 7_Supplement 1 April 2023
MRS 19th Biennial Congress, Buenos Aires
METSCAN™, a novel and proprietary algorithm to predict the metastatic potential of primary tumor patients. Tanvi Singh1, Ankesh Khemani2, Samrat Roy2, Debabani Roy Chowdhury2, Juhi Tayal3, Anurag Mehta3, Dinesh Doval3 and Arnab Roy Chowdhury2
BACR 60th Anniversary Meeting
Samrat Roy, Rajesh Kumar RK, Sundarajan Kannan, Debabani Roy Chowdhury, Manoj Pandre, Arnab Roy Chowdhury Exploiting the differential cellular biomechanics between metastatic and non-metastatic cells as a tool for predictive diagnostics., Mestastop Solutions Pvt. Ltd, Bangalore, India
Innovative Cancer Science: Translating Biology to Medicine
Samrat Roy*, Manoj Pandre*, Sundarajan Kannan, Rajesh Kumar RK, Chinmaya Amarkanth, Debabani Roy Chowdhury & Arnab Roy Chowdhury Survival and colonisation axis of metastasised cells in the secondary tissue: to target or not to target?, Mestastop Solutions Pvt. Ltd, Bangalore, India
https://mestastop.com/wp-content/uploads/2023/12/EACR_2022_Abstract_Book.pdf
Seed and Soil – In Vivo Models of Metastases
Amit Sharma1,2, Debabani Roy Chowdhury1, Samrat Roy1, Garima Sharma2, Manoj Pandre1, Sundarajan Kannan1, Soo-Woong Lee2, Sin-Hyeog Im2 and Arnab Roy Chowdhury1*. A novel, orthotopic spontaneous metastasis animal model for drug discovery that works in only six weeks. 1Mestastop Solutions Pvt. Ltd, Bangalore, India and 2Immunobiome Inc, Pohang, Gyeongbuk, South Korea.
Metastasis Research Society
Manoj Pandre, Debabani Roy Chowdhury, Sundarajan Kannan, Samrat Roy, Rajesh Kumar and Arnab Roy Chowdhury. Tumor Cell-induced platelet aggregation is independent of tumor invasiveness as observed from both cell lines and primary tumors,
Mestastop Solutions Private Limited, Bangalore, India.
1. Arnab Roy Chowdhury, Debabani Roy Chowdhury, Manoj Pandre, Samrat Roy, Sundarajan Kannan, John W. Ellingboe. Abstract 2868: A cell based phenotypic assay platform for cancer metastasis drug discovery and diagnostics, Mestastop Solutions Pvt. Ltd, Bangalore, India.
https://cancerres.aacrjournals.org/content/81/13_Supplement/2868
2. Samrat Roy, Debabani Roy Chowdhury, Manoj Pandre, Sundarajan Kannan, Rajesh Kumar RK, Amit K. Sharma, John W. Ellingboe, Arnab Roy Chowdhury. Abstract 2841: Dissecting tumorigenesis and metastatic properties of cell lines by phenotypic functional assays and plasticity ratio (PR), Mestastop Solutions Private Limited, Bangalore, India.
https://cancerres.aacrjournals.org/content/81/13_Supplement/2841
European Association for Cancer Research
A. Roy Chowdhury, M. Pandre, D. Roy Chowdhury, S. Roy, S. Kannan, R. Kumar, J. Ellingboe, A. Kamath and A. Sharma. The role of plasticity ratio (PR) in differentiating between metastatic and tumorigenic properties in cell lines and patient tumor samples, Mestastop Solutions Private Limited, Bangalore, India.
Download PDF Form
Name
Email address
Submit
Home
Publications
